Common side effects (may affect up to 1 in 10 people): * Pain, redness, or swelling at the injection site * Nausea * Headache Uncommon side effects (may affect up to 1 in 100 people): * Diarrhea * Dizziness * Allergic reactions such as skin rash, itching, or hives Rare side effects (may affect up to 1 in 1,000 people): * Severe allergic reaction (anaphylaxis) with symptoms like difficulty breathing, swelling of the face or throat, and a drop in blood pressure
The same principles that apply to peptide delivery generally apply to GLP-1 delivery specifically
[DOI] [PubMed] [Google Scholar] 73.Leffa D.T., Bellaver B., de Oliveira C., de Macedo I.C., de Freitas J.S., Grevet E.H., Caumo W., Rohde L.A., Quincozes-Santos A., Torres I.L.S
3,082.64 g/mol Purity 98% CAS No
Patients who commit to and maintain lifestyle changes in diet and exercise are more likely to keep a substantial amount of the weight off after discontinuing GLP-1 medications
Description AOD9604 AOD9604 Research Peptide Product Overview AOD9604 is a modified peptide fragment derived from the C-terminal region of human growth hormone, developed specifically for research applications involving metabolic signaling and adipose tissue pathway models